Click HereTherapeutic Options: Medicines not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
AZCERT today unveiled a critically important update to its CredibleMeds® mobile app, a revolutionary tool designed to help healthcare providers and patients navigate the complex world of medication safety. This comprehensive mobile application…
AZCERT's Scientific Review Committee has found substantial evidence that Opipramol (antidepressant), Revumenib (anticancer) and Sitafloxacin (antibiotic) are associated with the development of QT prolongation but lack convincing evidence of causing…
AZCERT's Scientific Review Committee has found substantial evidence re: the following medications. As demonstrated by these revisions, the QTdrugs list is dynamic and changes regularly. To perform a quick search of the Lists we recommend using the…
December 12, 2023
Re: Changes to the QTdrugs List and List of Drugs to Avoid in cLQTS
Dear CredibleMeds Registrants:
AZCERT's Scientific Review Committee has found substantial evidence that Triclabendazole (antiparasitic) is associated with…
AZCERT's Scientific Review Committee has found substantial evidence that Pacritinib (anticancer), Vernakalant (antiarrhythmic) and Fexinidazole (antiparasitic) are associated with the development of QT prolongation but lack convincing evidence…
TUCSON, AZ – CredibleMeds®, the internationally recognized authority on drug safety, has been awarded a three-year contract from the Safe Use Initiative of the U.S. Food and Drug Administration (FDA) to further their mutual goal of promoting and…
Recent publications in the medical literature have cited increased mortality associated with erythromycin, azithromycin, and levofloxacin. In a search for a possible explanation for the increased number of deaths with these drugs
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
